Cargando…
Reduced replication origin licensing selectively kills KRAS-mutant colorectal cancer cells via mitotic catastrophe
To unravel vulnerabilities of KRAS-mutant CRC cells, a shRNA-based screen specifically inhibiting MAPK pathway components and targets was performed in CaCo2 cells harboring conditional oncogenic KRAS(G12V). The custom-designed shRNA library comprised 121 selected genes, which were previously identif...
Autores principales: | Gastl, Bastian, Klotz-Noack, Kathleen, Klinger, Bertram, Ispasanie, Sylvia, Salib, Krenoula Hani Fouad, Zuber, Johannes, Mamlouk, Soulafa, Bublitz, Natalie, Blüthgen, Nils, Horst, David, Morkel, Markus, Schäfer, Reinhold, Sers, Christine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7330027/ https://www.ncbi.nlm.nih.gov/pubmed/32612138 http://dx.doi.org/10.1038/s41419-020-2704-9 |
Ejemplares similares
-
Reverse engineering a hierarchical regulatory network downstream of oncogenic KRAS
por: Stelniec-Klotz, Iwona, et al.
Publicado: (2012) -
Similar but different: distinct roles for KRAS and BRAF oncogenes in colorectal cancer development and therapy resistance
por: Morkel, Markus, et al.
Publicado: (2015) -
Cell type-dependent differential activation of ERK by oncogenic KRAS in colon cancer and intestinal epithelium
por: Brandt, Raphael, et al.
Publicado: (2019) -
Mitogen‐activated protein kinase activity drives cell trajectories in colorectal cancer
por: Uhlitz, Florian, et al.
Publicado: (2021) -
Robust in-silico identification of Cancer Cell Lines based on RNA and targeted DNA sequencing data
por: Otto, Raik, et al.
Publicado: (2019)